Search - tctmd.com

Displaying 81 - 100 of 1123

Sort: Relevancy | Date

Presentation TCT 2023

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

Exemplary Cases From the LIFE-BTK Trial

Presenter: Lawrence Garcia

October 25, 2023

Presentation TCT 2023

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

Presenter: Raghu Kolluri

October 25, 2023

Presentation TCT 2023

LIFE-BTK: The Top Line Results and Beyond

Presenter: Sahil Parikh

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 25, 2023

Presentation TCT 2023

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 497: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 4 Clinical Year Outcomes

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

Presenter: SIMONE FEZZI

October 25, 2023

Presentation TCT 2023

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

Presenter: Stefano Galli

October 25, 2023

Presentation TCT 2023

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

Presenter: Ramon Varcoe

October 25, 2023

Presentation TCT 2023

TCT 591: Preclinical Evaluation of a Novel Bioresorbable Sirolimus Eluting Magnesium-Alloy Scaffold in a Healthy Swine Coronary Arteries up to 540 Days

Presenter: Sho Torii

October 25, 2023

Presentation TCT 2023

TCT 576: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final 5 Year Clinical Outcomes

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 81: Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 36-Month Outcomes of the BIOSOLVE-IV Registry

Presenter: Gregory Starmer

October 25, 2023

Presentation TCT 2023

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Presenter: Eric Secemsky

October 25, 2023

Presentation TCT 2023

TCT 566: Tyrosine Polycarbonate Bioresorbable Scaffold for Below-the Knee Application: Pilot Study of Biocompatibility in Small Caliber Porcine Peripheral Arteries

Presenter: Mateusz Kachel

October 25, 2023

Presentation TCT 2023

R3 Vascular MAGNITUDE Bioresorbable Drug Eluting Scaffold

Presenter: Juan Granada

October 24, 2023

Presentation TCT 2023

MeRes Thin-Strut Scaffold

Presenter: Ricardo Costa

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

Advertisement

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

Exemplary Cases From the LIFE-BTK Trial

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

LIFE-BTK: The Top Line Results and Beyond

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

TCT 497: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 4 Clinical Year Outcomes

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

TCT 591: Preclinical Evaluation of a Novel Bioresorbable Sirolimus Eluting Magnesium-Alloy Scaffold in a Healthy Swine Coronary Arteries up to 540 Days

TCT 576: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final 5 Year Clinical Outcomes

TCT 81: Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 36-Month Outcomes of the BIOSOLVE-IV Registry

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

TCT 566: Tyrosine Polycarbonate Bioresorbable Scaffold for Below-the Knee Application: Pilot Study of Biocompatibility in Small Caliber Porcine Peripheral Arteries

R3 Vascular MAGNITUDE Bioresorbable Drug Eluting Scaffold

MeRes Thin-Strut Scaffold

What’s Going to Be Hot at TCT 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content